Buchumschlag

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Goldschmidt, Hartmut (VerfasserIn) , Mai, Elias K. (VerfasserIn) , Hose, Dirk (VerfasserIn) , Jauch, Anna (VerfasserIn) , Hillengaß, Jens (VerfasserIn) , Raab, Marc-Steffen (VerfasserIn) , Bertsch, Uta (VerfasserIn) , Hielscher, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Leukemia
Year: 2018, Jahrgang: 32, Pages: 383-390
ISSN:1476-5551
DOI:10.1038/leu.2017.211
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1038/leu.2017.211
Verlag, Volltext: https://www.nature.com/articles/leu2017211
Volltext
Verfasserangaben:H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vellenga, M. Pfreundschuh, M.J. Kersten, C. Scheid, S. Croockewit, R. Raymakers, D. Hose, A. Potamianou, A. Jauch, J. Hillengass, M. Stevens-Kroef, M.S. Raab, A. Broijl, H.W. Lindemann, G.M.J. Bos, P. Brossart, M. van Marwijk Kooy, P. Ypma, U. Duehrsen, R.M. Schaafsma, U. Bertsch, T. Hielscher, Le Jarari, H.J. Salwender and P. Sonneveld

MARC

LEADER 00000caa a2200000 c 4500
001 1581140193
003 DE-627
005 20221121123334.0
007 cr uuu---uuuuu
008 180920s2018 xx |||||o 00| ||eng c
035 |a (DE-627)1581140193 
035 |a (DE-576)511140193 
035 |a (DE-599)BSZ511140193 
035 |a (OCoLC)1341019039 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
245 1 0 |a Bortezomib before and after high-dose therapy in myeloma  |b long-term results from the phase III HOVON-65/GMMG-HD4 trial  |c H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vellenga, M. Pfreundschuh, M.J. Kersten, C. Scheid, S. Croockewit, R. Raymakers, D. Hose, A. Potamianou, A. Jauch, J. Hillengass, M. Stevens-Kroef, M.S. Raab, A. Broijl, H.W. Lindemann, G.M.J. Bos, P. Brossart, M. van Marwijk Kooy, P. Ypma, U. Duehrsen, R.M. Schaafsma, U. Bertsch, T. Hielscher, Le Jarari, H.J. Salwender and P. Sonneveld 
264 1 |c 2018 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 04 July 2017 
500 |a Gesehen am 20.09.2018 
700 1 |a Mai, Elias K.  |d 1985-  |e VerfasserIn  |0 (DE-588)1049182545  |0 (DE-627)781300274  |0 (DE-576)403130999  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Jauch, Anna  |d 1959-  |e VerfasserIn  |0 (DE-588)1025525140  |0 (DE-627)722525362  |0 (DE-576)168357496  |4 aut 
700 1 |a Hillengaß, Jens  |d 1974-  |e VerfasserIn  |0 (DE-588)124918549  |0 (DE-627)368073823  |0 (DE-576)294568298  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
700 1 |a Bertsch, Uta  |e VerfasserIn  |0 (DE-588)1026849861  |0 (DE-627)727494163  |0 (DE-576)372176224  |4 aut 
700 1 |a Hielscher, Thomas  |e VerfasserIn  |0 (DE-588)1159594791  |0 (DE-627)1022977768  |0 (DE-576)50506068X  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 32(2018), Seite 383-390  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Bortezomib before and after high-dose therapy in myeloma long-term results from the phase III HOVON-65/GMMG-HD4 trial 
773 1 8 |g volume:32  |g year:2018  |g pages:383-390  |g extent:8  |a Bortezomib before and after high-dose therapy in myeloma long-term results from the phase III HOVON-65/GMMG-HD4 trial 
856 4 0 |u http://dx.doi.org/10.1038/leu.2017.211  |x Verlag  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu2017211  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180920 
993 |a Article 
994 |a 2018 
998 |g 1159594791  |a Hielscher, Thomas  |m 1159594791:Hielscher, Thomas  |d 140000  |e 140000PH1159594791  |k 0/140000/  |p 29 
998 |g 1026849861  |a Bertsch, Uta  |m 1026849861:Bertsch, Uta  |d 910000  |d 910100  |e 910000PB1026849861  |e 910100PB1026849861  |k 0/910000/  |k 1/910000/910100/  |p 28 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 124918549  |a Hillengaß, Jens  |m 124918549:Hillengaß, Jens  |d 910000  |d 910100  |e 910000PH124918549  |e 910100PH124918549  |k 0/910000/  |k 1/910000/910100/  |p 17 
998 |g 1025525140  |a Jauch, Anna  |m 1025525140:Jauch, Anna  |d 910000  |d 911500  |e 910000PJ1025525140  |e 911500PJ1025525140  |k 0/910000/  |k 1/910000/911500/  |p 16 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |d 50000  |e 910000PH139824995  |e 910100PH139824995  |e 50000PH139824995  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 14 
998 |g 1049182545  |a Mai, Elias K.  |m 1049182545:Mai, Elias K.  |d 910000  |d 910100  |e 910000PM1049182545  |e 910100PM1049182545  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1581140193  |e 3025898771 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"note":["Published: 04 July 2017","Gesehen am 20.09.2018"],"title":[{"subtitle":"long-term results from the phase III HOVON-65/GMMG-HD4 trial","title_sort":"Bortezomib before and after high-dose therapy in myeloma","title":"Bortezomib before and after high-dose therapy in myeloma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["H. Goldschmidt, H.M Lokhorst, E.K. Mai, B. van der Holt, I.W. Blau, S. Zweegman, K.C. Weisel, E. Vellenga, M. Pfreundschuh, M.J. Kersten, C. Scheid, S. Croockewit, R. Raymakers, D. Hose, A. Potamianou, A. Jauch, J. Hillengass, M. Stevens-Kroef, M.S. Raab, A. Broijl, H.W. Lindemann, G.M.J. Bos, P. Brossart, M. van Marwijk Kooy, P. Ypma, U. Duehrsen, R.M. Schaafsma, U. Bertsch, T. Hielscher, Le Jarari, H.J. Salwender and P. Sonneveld"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"32046699X","disp":"Bortezomib before and after high-dose therapy in myeloma long-term results from the phase III HOVON-65/GMMG-HD4 trialLeukemia","type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-"}],"note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"part":{"pages":"383-390","year":"2018","extent":"8","text":"32(2018), Seite 383-390","volume":"32"},"language":["eng"]}],"recId":"1581140193","id":{"eki":["1581140193"]},"person":[{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"family":"Mai","display":"Mai, Elias K.","given":"Elias K.","role":"aut"},{"display":"Hose, Dirk","family":"Hose","given":"Dirk","role":"aut"},{"family":"Jauch","display":"Jauch, Anna","role":"aut","given":"Anna"},{"family":"Hillengaß","display":"Hillengaß, Jens","given":"Jens","role":"aut"},{"display":"Raab, Marc-Steffen","family":"Raab","given":"Marc-Steffen","role":"aut"},{"role":"aut","given":"Uta","family":"Bertsch","display":"Bertsch, Uta"},{"role":"aut","given":"Thomas","display":"Hielscher, Thomas","family":"Hielscher"}],"language":["eng"]} 
SRT |a GOLDSCHMIDBORTEZOMIB2018 

Ähnliche Einträge